Evidence map›Paper›PMID 40041425›Full record

ArticleCurrent trends in internal medicine2023

An Effective Straightforward Protocol for the Treatment of Graves' Hyperthyroidism for Primary Care Providers.

Felisha Eugenio, Syed M Kazim Raza, Ishmum Hasan, Christina Moldovan, Mohan Zopey, Mayer B Davidson, Theodore C Friedman

Abstract read
In one paragraph

Article in Current trends in internal medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Felisha EugenioCharles R. Drew University of Medicine and Science.
Syed M Kazim RazaCharles R. Drew University of Medicine and Science.
Ishmum HasanCharles R. Drew University of Medicine and Science.
Christina MoldovanCharles R. Drew University of Medicine and Science.
Mohan ZopeyCharles R. Drew University of Medicine and Science.
Mayer B DavidsonCharles R. Drew University of Medicine and Science.
Theodore C FriedmanCharles R. Drew University of Medicine and Science.

Funding

The Next Generation Substance Abuse Research Training at Charles R. Drew University (CDU) and UCLA (NGSART-CU)R25DA050723 · NIDA · CHARLES R. DREW UNIVERSITY OF MED & SCI · PI FRIEDMAN, THEODORE C · 2020 to 2024
$1.4M
NIDA NIH HHS R25 DA050723
6 · The paper itself

Abstract

Background: The prevalence of hyperthyroidism is very common in the United States (approximately 1.2%) with Graves' Disease (GD) being the most common non-iatrogenic cause. The limited number of endocrinologists and their concentration in larger cities means that primary care providers (PCPs) must treat a large number of these patients. This paper provides an effective, straightforward protocol for them to do so. Material & Methods: Patients with GD hyperthyroidism were referred to a county endocrinology clinic by PCPs in clinics that cared for medically underserved, mostly minority patients, a challenging population to treat. Hyperthyroidism was diagnosed by elevated free T Results: At the initial visit, 155 patients were, and 54 patients were not, respectively, taking an anti-thyroid drug. At the initial visit, patients either remained on methimazole, were started on the drug or were switched to it from propylthiouracil. The 209 patients were followed for up to 18 months. The protocol rapidly reversed the hyperthyroidism in most patients and at the end of the study, 72% were euthyroid, 19% were hyperthyroid and 9% were hypothyroid. Medication non-adherence probably accounted for those who were hyperthyroid at that time. Conclusion: PCPs following this protocol will enable them to effectively treat patients with GD hyperthyroidism.

Indexed as

Graves’ Disease’HyperthyroidismMethimazoleProtocol for treatment

Identifiers

PMID40041425
PMCPMC11878676

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.